DANVILLE - Gov. Tom Corbett announced Friday a $100,000 "Discovered in PA - Developed in PA" grant to support innovative genomic medical research to Geisinger Health System.

"One way we are creating a brighter future in Pennsylvania is through supporting organizations that show a commitment to innovation and bold invention," said Corbett. "Geisinger's project, intersecting telemedicine and genomics, demonstrates why Pennsylvania has become known for its world-class medical research."

The governor was joined Friday by Dr. Glenn Steele Jr., president and CEO, Geisinger Health System; Geisinger officials, and Department of Health Secretary Michael Wolf. Prior to the award announcement, the governor took part in a demonstration of Geisinger's eICU® telemedicine system.

"We are honored to be awarded a D2PA grant, which will be used by the Geisinger Genomic Medicine Institute to improve care for Pennsylvanians in the future," Steele said.

The Genomic Medicine Center will be home to a world-class, state-of-the-art "Tele-Genomics" facility in the Wilkes-Barre area. Patients will be able to have genomic sequencing completed, interpreted and applied to their healthcare by a team of physician geneticists, genetic counselors and other medical specialists.

Geisinger will also act as a resource to other institutions, providers and patients who seek a second opinion, and we will invite individuals, healthcare providers and genomic scientists to participate in efforts to bring diagnostic insight to patient care.

Geisinger Health System serves more than 2.6 million residents throughout 44 counties in central and northeastern Pennsylvania and has 20,800 employees, including a 1,000-member multi-specialty group practice, eight hospital campuses, two research centers and a 450,000-member health plan.